A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
New research has shown that the introduction childhood screening for type 1 diabetes is ‘effective’ and would help reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results